Lyell Immunopharma, Inc.
public$LYEL View Live Feed →
Total Raised
--
Contracts
--
Patents
--
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $LYEL
No disclosed congressional trades found in $LYEL.
Insider Trades (Form 4)
OTHER10% Owner
Innovative Cellular Therapeutics Holdings Ltd
44,000 shares Jul 28, 2026
OTHER10% Owner
Innovative Cellular Therapeutics Holdings Ltd
38,500 shares Jul 27, 2026
SELL10% Owner
Innovative Cellular Therapeutics Holdings Ltd
$13710 shares Jul 20, 2026
SELL10% Owner
Innovative Cellular Therapeutics Holdings Ltd
$13710 shares Jul 18, 2026
OTHER10% Owner
Innovative Cellular Therapeutics Holdings Ltd
76,000 shares Jul 1, 2026
OTHER10% Owner
Innovative Cellular Therapeutics Holdings Ltd
66,500 shares Jun 19, 2026
SELLPresident and CEO
Seely Lynn
$7,337388 shares Jun 15, 2026
SELLChief Scientific Officer
Lee Gary K.
$2,460130 shares Jun 15, 2026
Key People
Innovative Cellular Therapeutics Holdings Ltd
10% Owner
Insider
Seely Lynn
President and CEO
BoardInsider
Hill Stephen J
Chief Operating Officer
Insider
Lee Gary K
Chief Scientific Officer
Insider
Bulis Veronica Sanchez
VP, Corporate Controller
Insider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro